The Brighterside of News on MSN12 天
Tiny vortexes help detect dangerous viruses
Saliva-based diagnostics have emerged as a transformative approach in medical testing, offering a non-invasive and efficient ...
Sjögren’s antibody testing is done using a blood sample. It checks antibody levels, including anti-SS-A (also called anti-Ro) and anti-SS-B (also called anti-La). Anti-SS-A and anti-SS-B are ...
Lost spacecraft: SpaceX said Thursday that its Starship spacecraft — which was meant to lap Earth and splash down in the Indian Ocean — exploded not long after its 7th test flight took off ...
A pet owner who was curious about his rescue dog's mixed-breed heritage was left surprised at what a DNA test revealed. Max Matthai from Baltimore, Maryland, makes no bones about the fact he didn ...
This study provides useful insights into the ways in which germinal center B cell metabolism, particularly lipid metabolism, affects cellular responses. The authors use sophisticated mouse models to ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
NEW YORK — Werfen said Monday that it has received US Food and Drug Administration 510(k) clearance for its Aptiva Antiphospholipid Syndrome (APS) Immunoglobulin G (IgG) and Immunoglobulin M (IgM) ...
IGM Biosciences announced a strategic update to halt the development of two antibody therapies, imvotamab and IGM-2644, for autoimmune diseases due to insufficient results and strategic ...
The quality of immunoassays depends on the specificity and affinity of the receptor molecule (usually a monoclonal antibody) for the target; mAbs able to distinguish among the many fentanyl variants ...
The company now lists a lone, Sanofi-partnered IgM antibody asset on its pipeline ... it pivots from an in-house to outsourced analytical testing model. Those moves, coupled with other ...
IGM Biosciences announced they are halting the development of two investigational drugs for autoimmune and inflammatory diseases, imvotamab (an IgM-based CD20 X CD3 bispecific antibody T cell engager) ...